| Literature DB >> 11707659 |
Abstract
Pulmonary thromboembolism is the leading cause of maternal death in the UK. Optimal management of deep venous thrombosis and pulmonary thromboembolism requires an appreciation of risk factors, particularly thrombophilia, and signs or symptoms suggestive of venous thromboembolism, along with objective diagnosis and treatment with anticoagulants. Low molecular weight heparins are now replacing unfractionated heparin for the treatment of deep venous thrombosis and pulmonary thromboembolism in pregnancy because of the lower risk of side effects, ease of administration and reduced need for monitoring.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11707659 DOI: 10.1097/00001703-200112000-00004
Source DB: PubMed Journal: Curr Opin Obstet Gynecol ISSN: 1040-872X Impact factor: 1.927